cubeCONSENT 3.0 - For Subjects

N/A

Published by: CRScube
Downloads
Revenue

Description

'cubeCONSENT 3.0® - For Subjects' is a mobile app to access the subject portal for CRScube's eConsent solution 'cubeCONSENT 3.0®'.
App Features:
- Easy mobile phone access to clinical trial consent forms.
- Quick and secure eSignatures.
- Unlimited downloads of signed consent forms.
CRScube:
CRScube provides a comprehensive suite of eClinical solutions to CROs, Biotech, Pharmaceutical, Academic, and Non-Profit organizations globally. We are dedicated to providing the latest eClinical technology that is fast, flexible, and easy-to-use to streamline end-to-end operations for Phase I-IV, medical device, and Investigator-Initiated Trials.
Hide Show More...

Screenshots

CubeCONSENT 3.0 FAQ

  • Is CubeCONSENT 3.0 free?

    Yes, CubeCONSENT 3.0 is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is CubeCONSENT 3.0 legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does CubeCONSENT 3.0 cost?

    CubeCONSENT 3.0 is free.

  • What is CubeCONSENT 3.0 revenue?

    To get estimated revenue of CubeCONSENT 3.0 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in India yet.
Ratings History

CubeCONSENT 3.0 Reviews

No Reviews in India
App doesn't have any reviews in India yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

CubeCONSENT 3.0 Installs

Last 30 days

CubeCONSENT 3.0 Revenue

Last 30 days

CubeCONSENT 3.0 Revenue and Downloads

Gain valuable insights into CubeCONSENT 3.0 performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Category
Medical
Publisher
CRScube
Languages
English
Recent release
1.0.4 (1 year ago )
Released on
Jul 28, 2022 (2 years ago )
Last Updated
3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.